EMILY BERISWILL: Open Payments
NPI 1811432461 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,129 in 126 payments from 15 companies in 2025. Trend: 2023 $1,411 · 2024 $2,521 · 2025 $2,129
Food & beverage: $2,129
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 27 | $499 |
| ABBVIE INC. | 14 | $273 |
| PFIZER INC. | 20 | $238 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 16 | $212 |
| Novartis Pharmaceuticals Corporation | 14 | $208 |
| Axsome Therapeutics, Inc. | 8 | $165 |
| Dexcom, Inc. | 6 | $114 |
| AstraZeneca Pharmaceuticals LP | 4 | $100 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $85 |
| Lilly USA, LLC | 4 | $76 |
Products named: Wegovy, VRAYLAR, JARDIANCE, NURTEC ODT, LEQVIO, Auvelity, Dexcom G6 Transmitter, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
